Neumedicines Inc. Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Neumedicines Inc. is a biotechnology research company based in Pasadena, California, focused on developing and bringing to market therapeutic products and approaches aimed at unmet clinical and societal needs in oncology, hematology, and immunology. Its lead product candidate, recombinant human interleukin-12 (rHuIL-12) marketed as HemaMax™, is being explored for indications including the hematopoietic syndrome of acute radiation syndrome, skin cancers and other solid tumors, as well as blood disorders and malignancies. The company targets clinical settings where novel treatments could address significant treatment gaps, and positions itself within the biotechnology field by pursuing proprietary, innovative therapies. Neumedicines operates from its Pasadena headquarters with a small, specialized team, and its work centers on advancing oncology, hematology, and immunology therapeutic strategies through early-stage development and commercialization efforts.

Sign up for free to view info

Company overview Employee directory